{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:34:23Z","timestamp":1789565663797,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2013\/363982"],"award-info":[{"award-number":["2013\/363982"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2013\/363982"],"award-info":[{"award-number":["2013\/363982"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["#OPP1099374"],"award-info":[{"award-number":["#OPP1099374"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005728","type":"journal-article","created":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T13:52:12Z","timestamp":1467813132000},"page":"e1005728","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5597-9285","authenticated-orcid":false,"given":"Margarita","family":"Pons-Salort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hil","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel M.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-3952","authenticated-orcid":true,"given":"Hamid","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olen M.","family":"Kew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Grassly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,6]]},"reference":[{"key":"ref1","unstructured":"World Health Organization GPEI. The Polio Eradication &amp; Endgame Strategic Plan 2013\u20132018. 2013."},{"key":"ref2","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012\u2014conclusions and recommendations","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"OM Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"LN Alexander","year":"2004","journal-title":"JAMA"},{"key":"ref5","first-page":"846","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, July 2009-March 2011","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"CC Burns","year":"2014","journal-title":"J Infect Dis"},{"key":"ref7","unstructured":"World Health Organization GPEI. Reporting and classification of vaccine-derived polioviruses. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/VDPV_ReportingClassification.pdf\" xlink:type=\"simple\">http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/VDPV_ReportingClassification.pdf<\/ext-link>."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"HE Jenkins","year":"2010","journal-title":"N Engl J Med"},{"key":"ref9","first-page":"309","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2014-March 2015","volume":"90","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","first-page":"222","article-title":"Apparent global interruption of wild poliovirus type 2 transmission","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00705-006-0884-y","article-title":"Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania","volume":"152","author":"M Combiescu","year":"2007","journal-title":"Arch Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/525049","article-title":"A large vaccine-derived poliovirus outbreak on Madura Island\u2014Indonesia, 2005","volume":"197","author":"CF Estivariz","year":"2008","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"O Kew","year":"2002","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e88442","DOI":"10.1371\/journal.pone.0088442","article-title":"Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009-February 2011","volume":"9","author":"S Sharif","year":"2014","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population","volume":"203","author":"S Wassilak","year":"2011","journal-title":"J Infect Dis"},{"key":"ref16","unstructured":"Strategic Advisory Group of Experts Polio Working Group. Conference Call Notes, Thursday, 13 March 2015. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/immunization\/sage\/meetings\/2015\/april\/2_13_March_SAGE_Polio_WG_Meeting_2_Final.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/immunization\/sage\/meetings\/2015\/april\/2_13_March_SAGE_Polio_WG_Meeting_2_Final.pdf?ua=1<\/ext-link>."},{"key":"ref17","author":"NTJ Bailey","year":"1975"},{"key":"ref18","first-page":"367","article-title":"Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households","volume":"65","author":"HM Gelfand","year":"1957","journal-title":"Am J Hyg"},{"key":"ref19","first-page":"207","article-title":"Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis","volume":"58","author":"JL Melnick","year":"1953","journal-title":"Am J Hyg"},{"key":"ref20","first-page":"195","article-title":"The paralytic\/infected ratio in a susceptible population during a polio type I epidemic","volume":"39","author":"K Penttinen","year":"1961","journal-title":"Ann Med Exp Biol Fenn"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"PA Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.1323688111","article-title":"The role of older children and adults in wild poliovirus transmission","volume":"111","author":"IM Blake","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/JVI.02954-12","article-title":"Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria","volume":"87","author":"CC Burns","year":"2013","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1128\/JVI.02354-07","article-title":"Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range","volume":"82","author":"J Jorba","year":"2008","journal-title":"J Virol"},{"key":"ref25","unstructured":"ICF International. Demographic and Health Surveys (various) [Nigeria 2003: NGKR4BFL.SAV, NGHR4BFL.SAV, NGGE4BFL; Nigeria 2008: NGKR52FL.SAV, NGHR52FL.SAV, NGGE52FL; Nigeria 2013: NGKR6AFL.SAV, NGHR6AFL.SAV, NGGE6AFL]. Calverton, Maryland: ICF International."},{"key":"ref26","author":"KP Burnham","year":"2002"},{"key":"ref27","unstructured":"Therneau TM. A Package for Survival Analysis in S. R package version 2.37\u20137. 2014."},{"key":"ref28","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.R-project.org\/\" xlink:type=\"simple\">http:\/\/www.R-project.org\/<\/ext-link>."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/S2214-109X(13)70168-2","article-title":"Key issues in the persistence of poliomyelitis in Nigeria: a case-control study","volume":"2","author":"TD Mangal","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref30","article-title":"The Great North-South Divide in Nigeria. Financial Nigeria magazine. 2013","author":"M Hile","year":"2013","journal-title":"November"},{"key":"ref31","first-page":"175","article-title":"The epidemic of type 3 poliomyelitis in Poland in 1968","volume":"24","author":"J Kostrzewski","year":"1970","journal-title":"Epidemiological Review"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/viro.2000.0614","article-title":"The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland","volume":"278","author":"J Martin","year":"2000","journal-title":"Virology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1128\/JVI.77.23.12460-12465.2003","article-title":"Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future","volume":"77","author":"EA Korotkova","year":"2003","journal-title":"J Virol"},{"issue":"Suppl 1","key":"ref34","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1093\/infdis\/jit816","article-title":"Lot quality assurance sampling to monitor supplemental immunization activity quality: an essential tool for improving performance in polio endemic countries","volume":"210","author":"AE Brown","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"ref35","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1093\/infdis\/jit601","article-title":"Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis","volume":"210","author":"NC Grassly","year":"2014","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"TR Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"H Jafari","year":"2014","journal-title":"Science"},{"key":"ref38","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","author":"J John","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 1","key":"ref39","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1093\/infdis\/jit838","article-title":"Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation","volume":"210","author":"Tebbens RJ Duintjer","year":"2014","journal-title":"J Infect Dis"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T04:10:43Z","timestamp":1540354243000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005728"}},"subtitle":[],"editor":[{"given":"Marco","family":"Vignuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,6]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005728","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,6]]}}}